Autophagy dysregulation in Danon disease

Cell Death and Disease

Volumn 8, Issue 1, 2017, Pages

  Nascimbeni, Anna Chiara ^a,b   Fanin, Marina ^a   Angelini, Corrado ^c   Sandri, Marco ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b INSTITUT NECKER ENFANTS MALADES   (France)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

^d VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE VPS15; S6 KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; LAMP2 PROTEIN, HUMAN; PIK3R4 PROTEIN, HUMAN; TFEB PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BIOACCUMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DANON DISEASE; DISEASE SEVERITY; ENDOSOME; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LAMP2 GENE; LYSOSOME; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; ORGANELLE BIOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ADOLESCENT; ANIMAL; DISEASE MODEL; GENETICS; GLYCOGEN STORAGE DISEASE TYPE 2; METABOLISM; MOUSE; MUSCLE; MUTATION; PATHOLOGY;

ADOLESCENT; ADULT; ANIMALS; AUTOPHAGY; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; DISEASE MODELS, ANIMAL; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; GLYCOGEN STORAGE DISEASE TYPE IIB; HUMANS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOMES; MALE; MICE; MUSCLES; MUTATION; VACUOLAR SORTING PROTEIN VPS15;

EID: 85032140549     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.475     Document Type: Article

References (30)

1. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013; 6: 25-39.
2. Malicdan MC, Nishino I. Autophagy in lysosomal myopathies. Brain Pathol 2012; 22: 82-88.
3. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M et al. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10: 507-515.
4. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406: 906-910.
5. Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology 1981; 31: 51-57.
6. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406: 902-906.
7. Dice JF. Chaperone-mediated autophagy. Autophagy 2007; 3: 295-299.
8. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 2006; 73: 205-235.
9. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, Von Figura K et al. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 2002; 13: 3355-3368.
10. Sugie K, Noguchi S, Kozuka Y, Arikawa-Hirasawa E, Tanaka M, Yan C et al. Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol 2005; 64: 513-522.
11. Engel AG HR, Huie ML. Acid maltase deficiency In: EAaF-A C. (ed). Myology McGraw-Hill: New York, 2004, pp 1559-1586.
12. Raben N, Takikita S, Pittis MG, Bembi B, Marie SK, Roberts A et al. Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand. Autophagy 2007; 3: 546-552.
13. Raben N, Baum R, Schreiner C, Takikita S, Mizushima N, Ralston E et al. When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease. Autophagy 2009; 5: 111-113.
14. Nascimbeni AC, Fanin M, Masiero E, Angelini C, Sandri M. The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII). Cell Death Differ 2012; 19: 1698-1708.
15. Nascimbeni AC, Fanin M, Tasca E, Angelini C, Sandri M. Impaired autophagy affects acid alpha-glucosidase processing and enzyme replacement therapy efficacy in late-onset glycogen storage disease type II. Neuropathol Appl Neurobiol 2015; 41: 672-675.
16. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18: 39-51.
17. Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 1993; 260: 88-91.
18. Matsunaga K, Noda T, Yoshimori T. Binding Rubicon to cross the Rubicon. Autophagy 2009; 5: 876-877.
19. Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 2009; 11: 468-476.
20. Nemazanyy I, Blaauw B, Paolini C, Caillaud C, Protasi F, Mueller A et al. Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease. EMBO Mol Med 2013; 5: 870-890.
21. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 2011; 20: 3852-3866.
22. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA et al. A gene network regulating lysosomal biogenesis and function. Science 2009; 325: 473-477.
23. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332: 1429-1433.
24. Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J 2011; 30: 3242-3258.
25. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012; 31: 1095-1108.
26. Lindmo K, Stenmark H. Regulation of membrane traffic by phosphoinositide 3-kinases. J Cell Sci 2006; 119(Pt 4): 605-614.
27. Mansueto G, Armani A, Viscomi C, D'Orsi L, De Cegli R, Polishchuk EV et al. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab 2017; 25: 182-196.
28. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412.
29. Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-∗1. FASEB J 2006; 20: 583-585.
30. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.